ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pavord, I
Right arrow Articles by Knox, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pavord, I
Right arrow Articles by Knox, A
Eur Respir J 1996; 9: 217-219
Copyright © ERS Journals Ltd 1996


Clinical Trial

The effect of inhaled heparin on bronchial reactivity to sodium metabisulphite and methacholine in patients with asthma

I Pavord, T Mudassar, J Bennett, P Wilding, and A Knox

Inhaled heparin inhibits the early response to allergen and exercise-induced asthma, probably by inhibiting mast cell mediator release. Recent animal studies suggest that heparin might also inhibit cholinergic neurotransmission in asthma by restoring inhibitory M2 receptor function. We have tested the hypothesis that heparin inhibits neurally-mediated bronchoconstriction in asthma by examining the effect of inhaled heparin on bronchial reactivity to sodium metabisulphite. We also examined the effect of inhaled heparin on methacholine-induced bronchoconstriction to exclude a direct effect on airway smooth muscle. Eleven patients with mild asthma inhaled nebulized heparin (1,000 U.kg-1) or placebo (normal saline) in a randomized, double-blind fashion, 10 min before a challenge with sodium metabisulphite. Nine patients were also challenged with methacholine after the same dose of heparin or placebo. Inhaled heparin did not significantly change forced expiratory volume in one second (FEV1), nor did it alter the provocative dose of sodium metabisulphite or methacholine required to cause a 20% fall in FEV1 (PD20). Geometric mean sodium metabisulphite PD20 was 2.54 and 2.15 mumol after placebo and heparin, respectively (mean difference -0.24 doubling doses; 95% confidence interval (95% CI) -0.64-0.17). Geometric mean methacholine PD20 was 1.00 and 1.51 mumol after placebo and heparin, respectively (mean difference 0.6 doubling doses; 95% CI -0.25-1.5). Thus, heparin inhaled at doses sufficient to inhibit allergen and exercise-induced bronchoconstriction has no effect on the response to sodium metabisulphite and methacholine challenge in asthma. This argues against an inhibitory effect on neural pathways or airway smooth muscle.


This article has been cited by other articles:


Home page
Occup Med (Lond)Home page
M. Steiner, A. Scaife, S. Semple, G. Hulks, and J. G. Ayres
Sodium metabisulphite induced airways disease in the fishing and fish-processing industry
Occup. Med., October 1, 2008; (2008) kqn130v1.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. S. Niven and G. Argyros
Alternate Treatments in Asthma
Chest, April 1, 2003; 123(4): 1254 - 1265.
[Full Text] [PDF]


Home page
Eur Respir JHome page
K.E. Bendstrup, J. Gram, and J.I. Jensen
Effect of inhaled heparin on lung function and coagulation in healthy volunteers
Eur. Respir. J., April 1, 2002; 19(4): 606 - 610.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. E. BENDSTRUP, C. B. CHAMBERS, J. I. JENSEN, and M. T. NEWHOUSE
Lung Deposition and Clearance of Inhaled 99mTc-Heparin in Healthy Volunteers
Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1653 - 1658.
[Abstract] [Full Text]


Home page
Anesth. Analg.Home page
M. Yamakage, T. Matsuzaki, N. Tsujiguchi, T. Mori, and A. Namiki
The Direct Effects of Heparin and Protamine on Canine Tracheal Smooth Muscle Tone
Anesth. Analg., June 1, 1999; 88(6): 1232 - 1232.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the European Respiratory Society.